Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.69ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.69NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.45ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.45NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used